-
1 Comment
Nanosonics Limited is currently in a long term downtrend where the price is trading 16.1% below its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.6.
Nanosonics Limited's total revenue sank by 0.0% to $24M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $3M since the same quarter in the previous year.
Finally, its free cash flow fell by 123.6% to $-1M since the same quarter in the previous year.
Based on the above factors, Nanosonics Limited gets an overall score of 1/5.
Industry | Medical Instruments & Supplies |
---|---|
Sector | Healthcare |
ISIN | AU000000NAN9 |
CurrencyCode | EUR |
Exchange | F |
Beta | 1.62 |
---|---|
Dividend Yield | 0.0% |
Target Price | None |
PE Ratio | 159.0 |
Market Cap | 980M |
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for OQS.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024